Quick Answer
Tvardi Therapeutics, Inc. reported Total Assets of $32.07 million for fiscal year 2025.
Tvardi Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $32.07M | -8.9% |
| 2024 | $35.20M | -72.0% |
| 2023 | $125.84M | -30.9% |
| 2022 | $182.24M | -26.2% |
| 2021 | $247.06M | -8.9% |
| 2020 | $271.16M | +16.4% |
| 2019 | $232.96M | +22.1% |
| 2018 | $190.82M | +96.7% |
| 2017 | $97.00M | +52.0% |
| 2016 | $63.83M | -42.4% |
| 2015 | $110.90M | +98.3% |
| 2014 | $55.93M | +209.3% |
| 2013 | $18.08M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $39.02M | -24.0% | -10.8% |
| June 30, 2025 | $43.75M | -39.7% | +12.3% |
| March 31, 2025 | $38.95M | -56.8% | +10.6% |
| December 31, 2024 | $35.20M | -72.0% | -31.4% |
| September 30, 2024 | $51.33M | -55.5% | -29.2% |
| June 30, 2024 | $72.50M | -46.1% | -19.5% |
| March 31, 2024 | $90.10M | -41.2% | -28.4% |
| December 31, 2023 | $125.84M | -30.9% | +9.1% |
- Tvardi Therapeutics, Inc. showed a decrease of -8.9% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Tvardi Therapeutics, Inc.’s total assets has grown by 77.4% (from $18.08 million to $32.07 million).
- The most recent figure is from Tvardi Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: